KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EBT (2016 - 2025)

Historic EBT for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $5.0 billion.

  • Johnson & Johnson's EBT rose 2775.92% to $5.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $32.6 billion, marking a year-over-year increase of 9524.78%. This contributed to the annual value of $32.6 billion for FY2025, which is 9524.78% up from last year.
  • Per Johnson & Johnson's latest filing, its EBT stood at $5.0 billion for Q4 2025, which was up 2775.92% from $7.5 billion recorded in Q3 2025.
  • Johnson & Johnson's 5-year EBT high stood at $13.6 billion for Q1 2025, and its period low was -$1.3 billion during Q2 2023.
  • Moreover, its 5-year median value for EBT was $5.2 billion (2022), whereas its average is $5.2 billion.
  • Per our database at Business Quant, Johnson & Johnson's EBT plummeted by 12473.57% in 2023 and then skyrocketed by 38857.81% in 2024.
  • Quarter analysis of 5 years shows Johnson & Johnson's EBT stood at $3.8 billion in 2021, then soared by 34.37% to $5.2 billion in 2022, then dropped by 6.69% to $4.8 billion in 2023, then decreased by 19.46% to $3.9 billion in 2024, then grew by 27.76% to $5.0 billion in 2025.
  • Its EBT stands at $5.0 billion for Q4 2025, versus $7.5 billion for Q3 2025 and $6.5 billion for Q2 2025.